175 related articles for article (PubMed ID: 19578008)
1. The role of podocalyxin in health and disease.
Nielsen JS; McNagny KM
J Am Soc Nephrol; 2009 Aug; 20(8):1669-76. PubMed ID: 19578008
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression.
Somasiri A; Nielsen JS; Makretsov N; McCoy ML; Prentice L; Gilks CB; Chia SK; Gelmon KA; Kershaw DB; Huntsman DG; McNagny KM; Roskelley CD
Cancer Res; 2004 Aug; 64(15):5068-73. PubMed ID: 15289306
[TBL] [Abstract][Full Text] [Related]
4. Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Na+/H+-exchanger regulatory factor 2 and ezrin.
Takeda T
Clin Exp Nephrol; 2003 Dec; 7(4):260-9. PubMed ID: 14712354
[TBL] [Abstract][Full Text] [Related]
5. The human cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells.
Schopperle WM; Lee JM; Dewolf WC
Biochem Biophys Res Commun; 2010 Jul; 398(3):372-6. PubMed ID: 20599725
[TBL] [Abstract][Full Text] [Related]
6. Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins.
Tan PC; Furness SG; Merkens H; Lin S; McCoy ML; Roskelley CD; Kast J; McNagny KM
Stem Cells; 2006 May; 24(5):1150-61. PubMed ID: 16410385
[TBL] [Abstract][Full Text] [Related]
7. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin.
Doyonnas R; Kershaw DB; Duhme C; Merkens H; Chelliah S; Graf T; McNagny KM
J Exp Med; 2001 Jul; 194(1):13-27. PubMed ID: 11435469
[TBL] [Abstract][Full Text] [Related]
8. Podocalyxin is expressed in normal and leukemic monocytes.
Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
[TBL] [Abstract][Full Text] [Related]
9. Role of CD34 family members in lumen formation in the developing kidney.
Yang Z; Zimmerman SE; Tsunezumi J; Braitsch C; Trent C; Bryant DM; Cleaver O; González-Manchón C; Marciano DK
Dev Biol; 2016 Oct; 418(1):66-74. PubMed ID: 27542690
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.
Snyder KA; Hughes MR; Hedberg B; Brandon J; Hernaez DC; Bergqvist P; Cruz F; Po K; Graves ML; Turvey ME; Nielsen JS; Wilkins JA; McColl SR; Babcook JS; Roskelley CD; McNagny KM
Breast Cancer Res; 2015 Mar; 17(1):46. PubMed ID: 25887862
[TBL] [Abstract][Full Text] [Related]
11. Podocalyxin expression in malignant astrocytic tumors.
Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
[TBL] [Abstract][Full Text] [Related]
12. Ventricular enlargement associated with the panneural ablation of the podocalyxin gene.
Nowakowski A; Alonso-Martín S; González-Manchón C; Larrucea S; Fernández D; Vilar M; Cerdán S; Ayuso MS; Parrilla R
Mol Cell Neurosci; 2010 Jan; 43(1):90-7. PubMed ID: 19837166
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin in Normal Tissue and Epithelial Cancer.
Le Tran N; Wang Y; Nie G
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201212
[TBL] [Abstract][Full Text] [Related]
14. Podocalyxin selectively marks erythroid-committed progenitors during anemic stress but is dispensable for efficient recovery.
Maltby S; Hughes MR; Zbytnuik L; Paulson RF; McNagny KM
Exp Hematol; 2009 Jan; 37(1):10-8. PubMed ID: 19004540
[TBL] [Abstract][Full Text] [Related]
15. Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins.
Sassetti C; Van Zante A; Rosen SD
J Biol Chem; 2000 Mar; 275(12):9001-10. PubMed ID: 10722749
[TBL] [Abstract][Full Text] [Related]
16. Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion.
Debruin EJ; Hughes MR; Sina C; Lu A; Cait J; Jian Z; Lopez M; Lo B; Abraham T; McNagny KM
PLoS One; 2014; 9(10):e108881. PubMed ID: 25303643
[TBL] [Abstract][Full Text] [Related]
17. A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.
Wong BS; Shea DJ; Mistriotis P; Tuntithavornwat S; Law RA; Bieber JM; Zheng L; Konstantopoulos K
Cancer Res; 2019 Jun; 79(11):2878-2891. PubMed ID: 30975647
[TBL] [Abstract][Full Text] [Related]
18. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin.
Schopperle WM; Kershaw DB; DeWolf WC
Biochem Biophys Res Commun; 2003 Jan; 300(2):285-90. PubMed ID: 12504081
[TBL] [Abstract][Full Text] [Related]
19. Expression of caveolin-1 and podocalyxin in rat lungs challenged with 2-kDa macrophage-activating lipopeptide and Flt3L.
Tschernig T; Pabst R; Kasper M; El-Hadi M; Singh B
Cell Tissue Res; 2014 Apr; 356(1):207-16. PubMed ID: 24419512
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics.
Thomas SN; Tong Z; Stebe KJ; Konstantopoulos K
Biorheology; 2009; 46(3):207-25. PubMed ID: 19581728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
